Market News
Stay updated with the latest market trends, earnings, and economic indicators.

Mphasis to Glenmark - Jay Thakkar suggests 3 stocks to buy or sell for short-term in F&O segment
The Indian stock market is set to open lower, with the Gift Nifty at 23,882, down 97 points. Benchmark indices fell on profit-taking and rising crude oil prices, leading to cautious sentiment. Nifty 50 faces immediate hurdles at 24,100 and support at 23,800.
Ahead of Market: 10 things that will decide stock market action on Monday
Indian equity benchmarks closed modestly higher on Friday, with financial stocks leading the gains. The Nifty and Sensex edged up, though pharma and healthcare weakness capped the rise. Analysts noted the market's indecisive range-bound movement, awaiting a decisive breakout above 23,800 for further upward momentum or a fall towards 23,600.

Nifty could hit 27,000 once geopolitical tensions ease: Bajaj Finserv AMC CIO
Bajaj Finserv AMC CIO Nimesh Chandan projects 15% earnings growth for Nifty in FY28, with EPS rising to the ₹1,420–1,440 range, making valuations look attractive. He backs metals, construction, and cement as long-term plays on a global supply chain shift, holds gold and silver in the multi-asset portfolio, and flags El Niño and elevated US yields as key risks keeping Indian interest rates high in the near term.

Top Gainers & Losers on May 18: Gland Pharma, Coforge, PB Fintech, BSE, Voltas, Bharti Airtel among top gainers
Indian stocks marginally gained on May 18, driven by strong tech buying and pharma support, with Nifty 50 up 0.03% at 23,649 and BSE Sensex at 75,263. However, the broader market faced pressure as Nifty Midcap 100 and Nifty Smallcap 100 fell.
Market Trading Guide: Buy Zydus Lifesciences, Solar Industries on Friday for gains up to 15%
Nifty 50 closed higher for a second straight session, driven by banking, metal and pharma stocks despite IT weakness. Analysts see 23,800 as a crucial resistance level, while recommending Zydus Lifesciences and Solar Industries India for near-term gains on strong technical indicators and bullish momentum.
Sensex Today | Nifty 50 | Stock Market Live Updates: Sensex tumbles over 700 pts, Nifty below 24,000; con... - The Economic Times
Sensex Today | Nifty 50 | Stock Market Live Updates: Sensex tumbles over 700 pts, Nifty below 24,000; con...The Economic TimesWhy is market falling today? Sensex crashes 1,100 points, Nifty below 23,900. 6 key factorsThe Economic TimesStock market crashes today: Sensex falls 700 points, Nifty50 trades below 24,000 oil prices jump amid Middle East tensionsThe Times of IndiaSensex Today | Stock Market Live: Sensex pares losses but down 750 points, Nifty near 24,000; PSU bank stocks dragMoneycontrol.comSensex today | Stock Market Live: Sensex down 830 pts, Nifty falls 220 pts to 23,954.95; Tata Consumer, Max Healthcare top gainersBusinessLineStock Market Crash News Today Live Updates: Nifty Falls Below 23,900, Sensex Slides 1,000 Points; Vodafone Idea Shares Surge 8%NDTV ProfitSensex crashes 1,000 points: Why is the stock market falling today?India TodayNifty 50, Sensex prediction today: Check how Indian stock market is expected to trade on 11 MayMSNSensex crashes almost 1,200 points; investors lose ₹5 lakh crore: Key factors behind stock market crash explainedMint
Gold loans power Small Finance Banks' growth as microfinance asset quality weakens
Small Finance Banks are shifting focus to secured loans like gold loans. This move aims to stabilize their financial health and earnings. The unsecured microfinance sector continues to face high bad loan ratios. This strategic pivot is happening as regulators encourage diversification. Some larger banks are also growing their microfinance business. This change is crucial for long-term stability and growth.
Sun Pharma, 5 stocks hit 52-week highs, rally up to 25% in a month
Sensex surged 940 points as six BSE 100 stocks hit 52-week highs, signalling strong bullish momentum. Stocks like Adani Ports, Nestle India and Sun Pharma led gains, supported by solid monthly performance and positive investor sentiment in a rising market
Smallcap winners! Wockhardt, Tata Tech, CAMS, other stocks rally up to 11% despite overall market weakness
Smallcap stocks outperformed on Tuesday despite weak broader markets, with Wockhardt, Tata Tech and CAMS gaining up to 11% on strong Q4 earnings. While Nifty 50 slipped below 24,000 amid global concerns, improving momentum and technical indicators signal potential continued strength in the smallcap segment, according to Emkay.
Where to invest now: SBI MF prefers large caps, pharma, PSU banks
Ruchit Mehta, Head of Research at SBI Mutual Fund, prefers CDMO and hospital plays within pharma, citing stronger growth prospects over generics. He sees large caps as attractive on valuations, while midcaps require selectivity amid earnings risks. PSU banks may outperform in the near term due to stronger loan growth, but asset quality risks could emerge over the next 2–3 quarters if global disruptions persist.

Sensex jumps 639 points, Nifty reclaims 24,100 as Reliance Industries, Sun Pharma lead rebound
BSE Sensex and NSE Nifty rebounded after three losing sessions, led by Sun Pharma, Reliance Industries and midcaps, with all sectoral indices ending higher

Sun Pharma a trading play on dips, banks may face difficult June quarter: Dharmesh Kant
Dharmesh Kant, Head of Research at Chola Securities, said Sun Pharma’s all-cash acquisition of Organon could improve return ratios and support valuations, but may bring overall revenue growth down to single digits. He sees a trading opportunity in Sun Pharma on price dips. On banking, he said Q1 could be difficult as provisioning picks up, which may weigh on profitability even as asset quality and margins remain stable. Disclaimer: The views and tips expressed by investment experts on CNBCTV18.com are their own, not of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.